Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that baricitinib, a Janus kinase inhibitor, was more effective than traditional treatments for severe alopecia areata, with higher rates of significant hair regrowth after 6 months, despite mild-to-moderate side effects and some instances of weight gain.

In this study of women with androgenetic alopecia, researchers found no significant correlation between migraine occurrence and hair loss severity, although a significant relationship was observed between hair loss severity and pain intensity in those with migraine.

This study found that androgenetic alopecia may be a predictor of metabolic syndrome, emphasizing the importance of screening patients with severe hair loss for related health risks.

This study examined trichoscopic findings in androgenetic alopecia, reporting that hair diameter variability, vellus hairs, and the peripilar sign are valuable indicators for diagnosing this condition.

This study found a significant relationship between seborrheic dermatitis severity and androgenic alopecia patterns, suggesting potential benefits from treating dandruff symptoms in improving hair loss.

This study reported that the 1565 nm non-ablative fractional laser treatment significantly improved various hair growth indices in patients with androgenetic alopecia compared to 5% minoxidil, demonstrating its superior clinical efficacy and safety for treating this condition.

This study found that a combination therapy of autologous platelet-rich plasma and non-cross-linked hyaluronic acid increased hair density significantly in women with female androgenetic alopecia, without serious adverse effects.

In this study, PRP therapy did not show significant effectiveness in treating androgenetic alopecia in patients over a 6-month period, with 45% of participants reporting no improvement in hair growth, although adverse effects were minimal and non-serious.

This study found that in patients with androgenetic alopecia, cardiac troponin I levels positively correlated with age and certain heart functions, indicating possible cardiac involvement in the disease's progression.

This review examines the effectiveness of current treatments for androgenetic alopecia, offering plastic surgeons evidence-based guidance for choosing safe and effective options, but reports no new results.

This study found that AGA patients had higher serum and epidermal irisin levels, which were associated with metabolic syndrome, dyslipidemia, and abnormal carotid intima media thickness, suggesting potential irisin resistance affecting cardiometabolic health.

This study found that there was no significant difference between patients' and physicians' assessments of androgenetic alopecia severity, despite variability in individual cases.

In this study, PRP therapy initially improved hair density in androgenetic alopecia, but effects decreased over time, suggesting additional treatment may be needed for sustained results.

This study found that patients with androgenetic alopecia exhibited higher levels of cardiovascular risk markers, with hs-CRP identified as a significant independent predictor of cardiovascular disease risk.

This study found that hair mass index can effectively link hair productivity with clinical scalp coverage perception, suggesting its potential usefulness in diagnosing hair loss patterns and responses to treatment.

This study observed that among patients with PCOS, hirsutism was present in 75.63%, acne in 65%, and other skin conditions such as female pattern hair loss, acanthosis nigricans, and seborrhea in varying proportions, highlighting the dermatological impact of PCOS on patients' quality of life.

In this study, the application of topical 1% spironolactone in patients with androgenetic alopecia significantly increased hair count and thickness in females and increased hair count in males, though not all hair types showed significant changes.

This study found a significant correlation between metabolic syndrome components, particularly waist circumference and hypertension, and female pattern hair loss.

This study found no association between the androgen receptor gene and type II androgenetic alopecia in Egyptian women, suggesting it is not a useful biomarker for genetic predisposition.

This study found that non-ablative Er:YAG laser treatment, alone or combined with other therapies, effectively improved hair quality and reduced AGA grade in patients, with high satisfaction reported and no adverse reactions.

Asian women experiencing hair loss often feel embarrassed and unhappy, but hair transplantation can offer natural-looking results and improve their self-confidence.

This study found a significant negative correlation between serum SHBG levels and androgenetic alopecia severity in women, but not in men, while no significant correlation was observed for testosterone, estradiol, dehydroepiandrosterone sulfate, and vitamin D levels with hair loss severity across genders.

This article reviews the causes and clinical patterns of androgenetic alopecia in women and identifies systemic antiandrogens, estrogens, and topical 2% minoxidil solution as the only effective treatments.

In this study, combining photobiomodulation therapy and pulsed electromagnetic field therapy over 24 weeks significantly increased hair density in androgenetic alopecia patients compared to a sham device control, with minimal side effects reported.

This article explains the FUE technique for hair transplantation, its associated risks and complications, and outlines a protocol for maxillofacial surgeons, but reports no new clinical results.